-

City of Hope Recognized for the Fourth Consecutive Year as a ‘Top Hospital and Health System’ for Diversity, Equity and Inclusion

Fair360 ranked the national cancer organization No. 2, maintaining its position from 2023

LOS ANGELES--(BUSINESS WIRE)--City of Hope, one of the largest cancer research and treatment organizations in the United States, has once again been recognized by Fair360 (formerly DiversityInc) as one of the “Top Hospitals and Health Systems” in the country for diversity, equity and inclusion (DEI), ranking second on a list of 20 reputable health care organizations for the second year in a row. As the top National Cancer Institute-designated comprehensive cancer center, City of Hope is holding strong in the specialty ranking’s top 10 for the fourth consecutive year.

The Fair360 survey evaluates companies based on six key areas of workplace fairness, providing a trusted measure of transparency, equitable outcomes for employees and the effectiveness of fairness strategies and practices. The “Top Hospitals and Health Systems” list is industry-specific and based on a data-driven evaluation.

“This achievement underscores our institutional commitment to inclusion, collaboration and health equity, which helps us provide compassionate and culturally competent care that meets the needs of all communities. It also cultivates an inclusive environment where our patients and employees feel valued and heard,” said Angela L. Talton, senior vice president and system chief diversity, equity and inclusion officer.

The consecutive ranking is particularly meaningful as inclusivity and health equity are in the DNA of City of Hope, which is constantly striving to benefit its communities by decreasing health disparities in multiple ways. Efforts include co-authoring systemwide DEI training with minority business enterprise training vendors, organizing thoughtful community collaborations and addressing root causes of barriers to good health.

Internally, diversity, equity and inclusion remain at the heart of City of Hope’s initiatives and communications. Staff embarked on a “Situational Inclusivity Learning Journey,” complete with interactive modules and online classes to lay the groundwork for an inclusive culture based upon changing actions and behaviors to be more consciously inclusive. Notably, City of Hope’s holistic approach to recruitment and hiring also earned recognition as one of the “Top Companies for Talent Acquisition for Women of Color” by Fair360, a distinction earned through rigorous evaluation of new hire metrics, human capital management, inclusive onboarding practices, diverse candidate slate requirements and comprehensive employee benefits.

City of Hope’s national system of provider and research entities now serves approximately 144,000 patients each year, with more than 12,000 team members, 550 physicians and more than 1,000 scientists and researchers across a network of locations in California, Arizona, Illinois and Georgia.

About City of Hope

City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.

Contacts

Jessica Weeks
Jessica.Weeks@coh.org

City of Hope


Release Versions

Contacts

Jessica Weeks
Jessica.Weeks@coh.org

More News From City of Hope

Study Reveals How Gut Bacteria and Diet Can Reprogram Fat to Burn More Energy

LOS ANGELES--(BUSINESS WIRE)--Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and a leading research center for diabetes, the Broad Institute and Keio University have discovered how specific gut bacteria work together with diet to flip a metabolic switch — transforming energy‑storing white fat into calorie‑burning beige fat in mice. The study, published today in Nature, shows that a low‑protein diet activates a precise se...

City of Hope®: Early Diagnostics Will Stem the Surge of Colorectal Cancer in Younger Adults

LOS ANGELES--(BUSINESS WIRE)--Experts at City of Hope, one of the nation’s largest and most advanced cancer research and treatment organizations, say the surge in colorectal cancer in people under 50 — often compounded by delayed diagnoses and misinterpreted symptoms — requires age-specific research, treatments, education, and diagnostic tools. A blood test under development at City of Hope could become a breakthrough for detecting the disease early, making it part of an annual exam. Colorectal...

Second Annual $1 Million Stephenson Global Prize Now Open for Nominations

LOS ANGELES--(BUSINESS WIRE)--The Stephenson Global Prize, a $1 million award for innovation in pancreatic cancer research, has opened its second call for nominations. Awarded annually, the Prize recognizes visionary scientific leaders whose work is fundamentally changing the trajectory of pancreatic cancer research. Nominations are now open through May 1, 2026. The Stephenson Global Prize is part of a philanthropic program launched by A. Emmet Stephenson Jr., and Tessa Stephenson Brand. Their...
Back to Newsroom